Home » Topics » Regulatory

Regulatory
RSS

Harvard Scientific files IND for impotency treatment

May 3, 1996

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

Nasal propranolol claimed by RiboGene for angina Rx

May 3, 1996

Novel sertraline composition for mood disorders

May 3, 1996

DynaGen's lobeline transdermal system receives patent coverage

May 3, 1996

EPC-K claimed for ophthalmic use

May 3, 1996

MTP-5019 data revealed at AACR

May 3, 1996

Onco TCS slated to enter phase II

May 3, 1996

Matrix presents improved formulation of vinblastine

May 3, 1996

Zambon claims (S)-ibuprofen composition

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...